| 0.3 |
1.2 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.3 |
0.8 |
GO:1904395 |
retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 |
1.1 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.2 |
0.5 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.2 |
0.2 |
GO:0016539 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.2 |
0.5 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.7 |
GO:1903615 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.1 |
1.0 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 |
0.4 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
1.2 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
0.4 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.1 |
0.4 |
GO:1903989 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
| 0.1 |
1.0 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
0.4 |
GO:1905123 |
regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
| 0.1 |
0.3 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.1 |
0.4 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 |
0.3 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.1 |
0.7 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.1 |
0.2 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.1 |
0.2 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.1 |
0.5 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.3 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.1 |
0.5 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.2 |
GO:2000532 |
renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 0.1 |
0.2 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.1 |
0.1 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 |
0.5 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.7 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.1 |
0.2 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.1 |
0.3 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.1 |
0.2 |
GO:0036378 |
calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.1 |
0.1 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.3 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.1 |
0.4 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.2 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.0 |
0.1 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.0 |
0.1 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.0 |
0.2 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.0 |
0.2 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 |
0.1 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 0.0 |
0.3 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.6 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.3 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.1 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.0 |
0.1 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.0 |
0.2 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.0 |
0.2 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.0 |
0.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.1 |
GO:1900223 |
positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.0 |
0.0 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.0 |
0.3 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.0 |
0.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.0 |
0.8 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.3 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) positive regulation of high voltage-gated calcium channel activity(GO:1901843) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 |
0.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.2 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.0 |
0.3 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.4 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.0 |
0.3 |
GO:0010748 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.0 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.3 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.2 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.0 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.1 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.0 |
0.2 |
GO:0098704 |
fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.0 |
0.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 |
0.2 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.0 |
0.5 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.3 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.0 |
0.2 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.0 |
0.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.0 |
0.1 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.0 |
0.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.0 |
0.1 |
GO:0034764 |
positive regulation of transmembrane transport(GO:0034764) positive regulation of ion transmembrane transport(GO:0034767) |
| 0.0 |
0.2 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.0 |
0.1 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.0 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.3 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.1 |
GO:0060490 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.0 |
0.1 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.0 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.0 |
0.1 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 |
0.2 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 |
0.2 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.0 |
0.1 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 |
0.0 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.0 |
0.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.1 |
GO:1990418 |
response to sodium phosphate(GO:1904383) response to insulin-like growth factor stimulus(GO:1990418) |
| 0.0 |
0.2 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.4 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.0 |
0.1 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.0 |
0.1 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.0 |
0.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.0 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.0 |
0.5 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 |
0.1 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.0 |
0.2 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.0 |
0.1 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
0.1 |
GO:0042700 |
primary ovarian follicle growth(GO:0001545) luteinizing hormone signaling pathway(GO:0042700) |
| 0.0 |
0.2 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 |
0.2 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.1 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.0 |
0.5 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.2 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.0 |
0.4 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.0 |
0.1 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.0 |
0.2 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.0 |
0.1 |
GO:0000270 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 |
0.1 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.0 |
0.2 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.0 |
0.1 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.0 |
0.1 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) positive regulation of connective tissue replacement(GO:1905205) |
| 0.0 |
0.1 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.0 |
0.5 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
1.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.3 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.0 |
0.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.0 |
0.2 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 |
0.1 |
GO:0051140 |
positive regulation of activation of Janus kinase activity(GO:0010536) regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.0 |
0.1 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.0 |
0.1 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 |
0.1 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 |
0.5 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.2 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.0 |
0.3 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 |
0.4 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.0 |
0.1 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.0 |
0.3 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.0 |
0.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.4 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.3 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 |
0.0 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.0 |
0.2 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.5 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.0 |
0.3 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 |
0.2 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) peptidyl-serine autophosphorylation(GO:0036289) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) insulin metabolic process(GO:1901142) |
| 0.0 |
0.1 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.0 |
0.1 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.0 |
2.0 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 0.0 |
0.3 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.0 |
0.2 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.2 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.2 |
GO:0046959 |
habituation(GO:0046959) |
| 0.0 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.1 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.0 |
0.0 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.0 |
0.5 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 |
0.1 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.0 |
0.0 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.0 |
0.2 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
0.0 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.0 |
0.3 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.0 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.1 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.1 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.2 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.0 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.0 |
1.3 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.2 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.0 |
0.1 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.0 |
0.0 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.0 |
0.0 |
GO:0002856 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.0 |
0.1 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.0 |
1.4 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.0 |
GO:0009183 |
purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.0 |
0.0 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.0 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) angiotensin-mediated drinking behavior(GO:0003051) operant conditioning(GO:0035106) |
| 0.0 |
0.0 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
0.1 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.0 |
0.0 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.0 |
0.0 |
GO:1902004 |
positive regulation of beta-amyloid formation(GO:1902004) |
| 0.0 |
0.1 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 |
0.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.0 |
0.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.0 |
0.0 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.0 |
0.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.1 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.0 |
0.1 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 |
0.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.0 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.0 |
0.0 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.0 |
0.0 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.0 |
0.1 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.0 |
0.1 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.0 |
0.1 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.1 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
